Biomet Hip Replacement Lawsuit: Common Benefit and Expense Funds Established for Federal Biomet Hip Lawsuits, Bernstein Liebhard LLP Reports

The Firm is representing numerous Biomet hip lawsuit clients who have filed claims in the federal Biomet hip replacement litigation.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm is representing a number of clients in this proceeding, and we continue to hear from individuals who experienced metallosis, hip implant failure, and other painful complications, allegedly due to the M2a Magnum hip system.

New York, NY (PRWEB) February 14, 2014

The federal judge overseeing hundreds of Biomet hip replacement lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) alleging injury due to the metal-on-metal M2a Magnum hip implant has established Common Benefit and Expense Funds for the multidistrict litigation underway in U.S. District Court, Northern District of Indiana. According to a Case Management Order dated February 4, 2014, U.S. District Judge Robert L. Miller, Jr. established the funds to provide for the fair and equitable sharing of expenses and the costs of legal services incurred for the benefit of all plaintiffs who have cases pending in the proceeding. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“We are pleased to see the Biomet hip replacement litigation moving forward. Our Firm is representing a number of clients in this proceeding, and we continue to hear from individuals who experienced metallosis, hip implant failure, and other painful complications, allegedly due to the M2a Magnum hip system,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal consultations to M2a Magnum hip recipients who allegedly suffered serious and debilitating complications due to its metal-on-metal design.

Biomet Hip Lawsuit Settlement
Court documents indicate that more than 950 Biomet hip lawsuits are currently pending in the mulitidistrict litigation underway in the Northern District of Indiana. All of these claims similarly allege that metal debris shed as the result of the M2a Magnum hip’s all-metal design can accumulate to dangerous levels in recipients’ tissue and blood stream. This has the potential to cause serious and debilitating complications, including metallosis, pseudotumor formation, and premature failure of the hip implant.

According to court records, Judge Miller approved a Biomet hip replacement settlement on February 3, 2014, which will resolve hundreds of claims pending in the proceeding. Under the terms of the settlement, plaintiffs who received one of the affected Biomet hip replacements as part of an initial surgery that was rectified more than 180 days after it was implanted will be eligible for a base award of $200,000. To participate in the settlement program, plaintiffs must file their Biomet hip lawsuits no later than April 15, 2014.

According to an alert issued by the U.S. Food & Drug Administration (FDA) in January 2013, metal-on-metal hip implants like those involved in the Biomet hip replacement litigation may be more likely to fail prematurely than those made of other materials. The FDA has advised patients fitted with such devices to undergo blood testing for elevated levels of metal ions if they experience any symptoms that would indicate their hip is failing. The agency has also proposed new regulations that would subject all-metal hips to greater premarket testing, and which also require the manufactures of devices already on the market to conduct safety studies of those products in order to continue selling them.

Biomet hip replacement recipients who have allegedly experienced metallosis and other complications resulting in failure of an M2a Magnum hip may be entitled to compensation for their injury-related damages. Learn more about filing a Biomet hip lawsuit by visiting Bernstein Liebhard LLP’s website. To arrange for a free case review, call 800-511-5092 to speak with a member of our legal staff.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author